These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. Immunocompetent cell functions in mice infected with Friend leukemia virus. Bennett M, Steeves RA. J Natl Cancer Inst; 1970 May; 44(5):1107-19. PubMed ID: 4398242 [No Abstract] [Full Text] [Related]
33. [Study on nonmyeloablative allogeneic bone marrow transplantation in the treatment of L615 leukemia mice]. Xu KL, Ju JP, Pan XY, Du B, Li ZY, Lu QX. Zhonghua Xue Ye Xue Za Zhi; 2003 Jul; 24(7):372-5. PubMed ID: 12941194 [Abstract] [Full Text] [Related]
34. BCG in cancer immunotherapy: experimental and clinical trials of its use in treatment of leukemia minimal and or residual disease. Mathé G, Weiner R, Pouillart P, Schwarzenberg L, Jasmin C, Schneider M, Hayat M, Amiel JL, de Vassal F, Rosenfeld C. Natl Cancer Inst Monogr; 1973 Dec; 39():165-75. PubMed ID: 4595314 [No Abstract] [Full Text] [Related]
39. The influence of graft-versus-host reactivity, lymphocyte depletion, and cell dose on allogeneic bone marrow engraftment. Glass B, Uharek L, Gaska T, Gassmann W, Löffler H, Müller-Ruchholtz W. Bone Marrow Transplant; 1993 Oct; 12 Suppl 3():S41-7. PubMed ID: 8124257 [Abstract] [Full Text] [Related]
40. Leukemia induction in C3H mice following their inoculation with normal AKR lymphoid cells. Nemirovsky T, Trainin N. Int J Cancer; 1973 Jan 15; 11(1):172-7. PubMed ID: 4151449 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]